Research Grant
[Cite as https://purl.org/au-research/grants/nhmrc/520345]Researchers: Dr Michael Cater (Principal investigator)
Brief description Alzheimer’s disease (AD) is creating a growing burden upon Australian medical resources. Copper plays an important role in the development of AD and drugs designed to adjust brain copper levels are being tested for AD treatment and show therapeutic benefits. This project will determine how copper is involved in AD so that more effective drugs can be developed. Focus will primarily be on copper-binding proteins central to AD and establishing their role in AD development and progression.
Funding Amount $AUD 287,321.14
Funding Scheme Early Career Fellowships
Notes Peter Doherty Biomedical ECF
- nhmrc : 520345
- PURL : https://purl.org/au-research/grants/nhmrc/520345
